Published ahead of print on November 1, 2007, doi:10.1164/rccm.200701-014OC
Am. J. Respir. Crit. Care Med., Volume 177, Number 2, January 2008, 156-163
A more recent version of this article appeared on January 15, 2008
Submitted on January 2, 2007
Accepted on November 1, 2007
Autoantibodies in Patients with Chronic Obstructive Pulmonary Disease
Carol A Feghali-Bostwick1, Aneal S Gadgil1, Leo E Otterbein2, Joseph M Pilewski1, Michael W Stoner1, Eva Csizmadia2, Yingze Zhang1, Frank C Sciurba1, and Steven R Duncan1*
1 Division of Pulmonary, Allergy and Critical Care, University of Pittsburgh Medical Center, Pittsburgh, PA, USA,
2 Transplant Center, Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA
* To whom correspondence should be addressed. E-mail: duncsr{at}upmc.edu.
Background: Adaptive immune responses are present in patients with chronic obstructive pulmonary disease (COPD), and it has been postulated these processes could be autoreactive.
Objectives: To ascertain if humoral autoimmunity could play a role in COPD pathogenesis.
Methods: Circulating IgG autoantibodies were detected by immunofluorescence and immunoprecipitation. Immunohistochemistry and immunofluorescence were used to evaluate intrapulmonary IgG and complement (C3) deposition in human lung explants. Autoantibody pathogenicity was also investigated with an antibody-dependent cell-mediated cytotoxicity (ADCC) assay.
Measurements and Main Results: The prevalence of anti-HEp-2 epithelial cell autoantibodies in 47 smokers/former smokers with COPD (GOLD Stages 1-4) was greater than among eight subjects with a smoking history but normal spirometry, and 21 healthy, Never-Smoke Controls (68% vs. 13% vs. 10%, respectively, p<0.0001). Antibodies against primary pulmonary epithelial cells were found in 12/12 COPD vs. 3/12 Never-Smoke Controls (p<0.001). Self-antigens immunoprecipitated from 34/35 (97%) of COPD plasmas (vs. 0/12 Never-Smoke Controls). Antibodies against a particular 130 kDa autoantigen (n=7) were associated with decreased body mass index (23.2±2.1 vs. 29.5±1.0 kg/M2, p=0.007). Intrapulmonary immune complexes were present in 6/6 and C3 was seen in 5/6 COPD lung explants, unlike 0/6 and 1/6 normals, respectively. Cytotoxicity of pulmonary epithelial cells by allogeneic mononuclear cells also increased 46% after incubation with COPD plasmas (n=10), compared to identical treatments with eight normal specimens (p=0.03).
Conclusions: IgG autoantibodies with avidity for pulmonary epithelium, and the potential to mediate cytotoxicity, are prevalent in COPD patients. Autoreactive adaptive immune responses may be important in the etiology of this disease.
Key words: autoimmunity, humoral immunity, B-cells, emphysema
This article has been cited by other articles:

|
 |

|
 |
 
M. Shan, H.-F. Cheng, L.-z. Song, L. Roberts, L. Green, J. Hacken-Bitar, J. Huh, F. Bakaeen, H. O. Coxson, C. Storness-Bliss, et al.
Lung Myeloid Dendritic Cells Coordinately Induce TH1 and TH17 Responses in Human Emphysema
Science Translational Medicine,
October 28, 2009;
1(4):
4ra10 - 4ra10.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. MacNee and R. M. Tuder
New Paradigms in the Pathogenesis of Chronic Obstructive Pulmonary Disease I
Proceedings of the ATS,
September 15, 2009;
6(6):
527 - 531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. G. Tzortzaki and N. M. Siafakas
A hypothesis for the initiation of COPD
Eur. Respir. J.,
August 1, 2009;
34(2):
310 - 315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. Brusselle, T. Demoor, K. R. Bracke, C-A. Brandsma, and W. Timens
Lymphoid follicles in (very) severe COPD: beneficial or harmful?
Eur. Respir. J.,
July 1, 2009;
34(1):
219 - 230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Cosio, M. Saetta, and A. Agusti
Immunologic Aspects of Chronic Obstructive Pulmonary Disease
N. Engl. J. Med.,
June 4, 2009;
360(23):
2445 - 2454.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Richens, D. J. Linderman, S. A. Horstmann, C. Lambert, Y.-Q. Xiao, R. L. Keith, D. M. Boe, K. Morimoto, R. P. Bowler, B. J. Day, et al.
Cigarette Smoke Impairs Clearance of Apoptotic Cells through Oxidant-dependent Activation of RhoA
Am. J. Respir. Crit. Care Med.,
June 1, 2009;
179(11):
1011 - 1021.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D Maclay, R. A Rabinovich, and W. MacNee
Update in Chronic Obstructive Pulmonary Disease 2008
Am. J. Respir. Crit. Care Med.,
April 1, 2009;
179(7):
533 - 541.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zhu, A. S. Gadgil, R. Givelber, M. P. George, M. W. Stoner, F. C. Sciurba, and S. R. Duncan
Peripheral T Cell Functions Correlate with the Severity of Chronic Obstructive Pulmonary Disease
J. Immunol.,
March 1, 2009;
182(5):
3270 - 3277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-R. Yang, H. Yao, S. Rajendrasozhan, S. Chung, I. Edirisinghe, S. Valvo, G. Fromm, M. J. McCabe Jr., P. J. Sime, R. P. Phipps, et al.
RelB Is Differentially Regulated by I{kappa}B Kinase-{alpha} in B Cells and Mouse Lung by Cigarette Smoke
Am. J. Respir. Cell Mol. Biol.,
February 1, 2009;
40(2):
147 - 158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Cottin, N. Fabien, C. Khouatra, A. Moreira, and J-F. Cordier
Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema
Eur. Respir. J.,
January 1, 2009;
33(1):
219 - 221.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Isajevs, I. Taivans, G. Strazda, U. Kopeika, M. Bukovskis, V. Gordjusina, and A. Kratovska
Decreased FOXP3 expression in small airways of smokers with COPD
Eur. Respir. J.,
January 1, 2009;
33(1):
61 - 67.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. T. Motz, B. L. Eppert, G. Sun, S. C. Wesselkamper, M. J. Linke, R. Deka, and M. T. Borchers
Persistence of Lung CD8 T Cell Oligoclonal Expansions upon Smoking Cessation in a Mouse Model of Cigarette Smoke-Induced Emphysema
J. Immunol.,
December 1, 2008;
181(11):
8036 - 8043.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Calabrese, S. Baraldo, E. Bazzan, F. Lunardi, F. Rea, P. Maestrelli, G. Turato, K. Lokar-Oliani, A. Papi, R. Zuin, et al.
IL-32, a Novel Proinflammatory Cytokine in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
November 1, 2008;
178(9):
894 - 901.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. F. Chung and I. M. Adcock
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Eur. Respir. J.,
June 1, 2008;
31(6):
1334 - 1356.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 American Thoracic Society
|
|
|